Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Conditions:   Head and Neck Carcinoma of Unknown Primary;   Locally Advanced Head and Neck Squamous Cell Carcinoma;   Locally Advanced Hypopharyngeal Squamous Cell Carcinoma;   Locally Advanced Laryngeal Squamous Cell Carcinoma;   Locally Advanced Nasopharyngeal Squamous Cell Carcinoma;   Locally A dvanced Oropharyngeal Squamous Cell Carcinoma Interventions:   Drug: Tolinapant;   Radiation: Radiation Therapy Sponsors:   Emory University;   Astex Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials